写在文章前的声明：在本文之前的说明：本文中所列的投资信息，只是一个对基金资产净值进行排行的客观描述，并无主观倾向性，也不是投资建议，纯属 娱乐性质。 | 排名 | 代码 | 基金简称 | 2025-08-20 | | 2025-08-19 | | 理业量 | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | 車位净值3 | 累计净值8 | 車位净值8 | 累计净值3 | | | 1 | 017744 | 嘉实绿色主题股票发起式A | 1.1888 | 1.1888 | 1.1232 | 1.1232 | 0.06 | | 2 | 017745 | 嘉实绿色主题股票发起式C | 1.1712 | 1.1712 | 1.1066 | 1.1066 | 0.06 | | 3 | 162214 | 宏利领先中小盘混合 | 0.9990 | 0.9990 | 0.9500 | 0.9500 | 0.04 | | 4 | 021492 | 中航远见领航混合发起C | 1.3618 | 1.4418 | 1.2951 | 1.3751 | 0.06 | | ...

Group 1 - The core viewpoint of the report indicates that the pharmaceutical and communication sectors performed well during the period, while the overall market saw declines in major indices [2][8][13] - The report highlights that the average return of actively managed equity funds decreased by 0.26%, while actively managed bond funds saw a slight increase of 0.08% [2][16] - The report notes that the long-term pure bond funds outperformed other bond categories, with an average return of 0.15% for the period [16][17] Group 2 - The report identifies that the pharmaceutical sector has shown strong performance, with several actively managed equity funds focused on this sector achieving high returns [14][15] - The report provides a detailed analysis of various fund categories, indicating that the average return for QDII funds varied significantly, with energy commodity QDII funds leading at 4.54% [18][20] - The report emphasizes that the average return for the equity funds in the Greater China region was notably high at 33.16% for the year [18][20]

Group 1 - The majority of stock and mixed funds achieved positive returns, with 89.57% reporting gains, and 52 funds exceeding a 5% return [1][2] - The Shanghai Composite Index rose by 0.43% to close at 3399.77 points, while the Shenzhen Component Index increased by 0.65%, and the ChiNext Index rose by 1.07% [1] - The top-performing sectors included pharmaceuticals, agriculture, and textiles, with respective increases of 2.30%, 1.72%, and 1.61% [1] Group 2 - The average net value growth rate for stock and mixed funds on June 9 was 0.68%, with 52 funds achieving over 5% growth [1][2] - The leading fund in terms of net value growth was Red Soil Innovation Healthcare Stock, with a growth rate of 7.36% [2] - Among the funds with over 5% growth, 9 belonged to Ping An Fund, while Great Wall Fund and Penghua Fund had 8 and 6 funds respectively [1][2] Group 3 - The funds with the highest net value declines included Gold Stock ETF, which fell by 1.11%, followed by Ping An and Guotai ETFs with declines of 1.10% and 1.09% respectively [2][3] - The data indicates a significant focus on healthcare-related funds, with multiple funds from Ping An Fund showing strong performance [1][2] - The report highlights the volatility in the gold sector, as evidenced by the performance of various gold-related ETFs [2][3]

Core Insights - The report indicates that the environmental protection sector performed well during the period, with QDII funds showing an average return that outperformed other fund types [1][7][17] - The Shanghai Composite Index experienced a slight decline of 0.03%, while the Shenzhen Component Index fell by 0.91% during the same period [1] - Among various fund types, QDII funds increased by 1.04%, contrasting with declines in actively managed stock funds, mixed funds, and bond funds [1] Fund Performance Summary - The environmental and pharmaceutical sectors were highlighted as strong performers in the recent 12 periods, with banks and beauty care also showing good performance [7] - Active stock funds focusing on the pharmaceutical sector yielded higher returns, with notable funds such as Hongtu Innovation Healthcare Stock Fund achieving a return of 9.67% [12][13] - In the bond market, convertible bond funds led with an average return of 3.90% year-to-date, while traditional bond funds showed mixed results [15][16] QDII Fund Insights - REITs QDII funds led the performance with a return of 2.41%, followed by equity funds focused on Europe and the US, which returned 1.70% [17][18] - The report notes that alternative asset classes, particularly gold-related QDII funds, have shown significant year-to-date growth of 25.91% despite a recent decline of 1.39% [17][18] - Representative QDII funds such as Morgan China Biopharmaceutical A and GF CSI Hong Kong Innovative Medicine ETF reported returns of 4.72% and 4.56%, respectively, during the period [19]